HUP0101640A3 - Certain thoil inhibitors of endothelin-converting enzyme - Google Patents

Certain thoil inhibitors of endothelin-converting enzyme

Info

Publication number
HUP0101640A3
HUP0101640A3 HU0101640A HUP0101640A HUP0101640A3 HU P0101640 A3 HUP0101640 A3 HU P0101640A3 HU 0101640 A HU0101640 A HU 0101640A HU P0101640 A HUP0101640 A HU P0101640A HU P0101640 A3 HUP0101640 A3 HU P0101640A3
Authority
HU
Hungary
Prior art keywords
thoil
endothelin
inhibitors
certain
converting enzyme
Prior art date
Application number
HU0101640A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUP0101640A2 publication Critical patent/HUP0101640A2/hu
Publication of HUP0101640A3 publication Critical patent/HUP0101640A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0101640A 1998-04-23 1999-04-21 Certain thoil inhibitors of endothelin-converting enzyme HUP0101640A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6526598A 1998-04-23 1998-04-23
PCT/EP1999/002690 WO1999055726A1 (en) 1998-04-23 1999-04-21 Certain thiol inhibitors of endothelin-converting enzyme

Publications (2)

Publication Number Publication Date
HUP0101640A2 HUP0101640A2 (hu) 2001-09-28
HUP0101640A3 true HUP0101640A3 (en) 2002-10-28

Family

ID=22061502

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101640A HUP0101640A3 (en) 1998-04-23 1999-04-21 Certain thoil inhibitors of endothelin-converting enzyme

Country Status (16)

Country Link
EP (1) EP1073674A1 (ru)
JP (1) JP4350306B2 (ru)
KR (1) KR20010034816A (ru)
CN (1) CN1297453A (ru)
AU (1) AU3819999A (ru)
BR (1) BR9909805A (ru)
CA (1) CA2323691A1 (ru)
HU (1) HUP0101640A3 (ru)
ID (1) ID26822A (ru)
IL (1) IL138246A0 (ru)
NO (1) NO20005293L (ru)
PL (1) PL343594A1 (ru)
RU (1) RU2000129510A (ru)
SK (1) SK15812000A3 (ru)
WO (1) WO1999055726A1 (ru)
ZA (1) ZA200004680B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423727B1 (en) 1998-04-23 2002-07-23 Novartis Ag Certain thiol inhibitors of endothelin-converting enzyme
US6426354B1 (en) 1998-04-23 2002-07-30 Novartis Ag Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
WO2001077095A2 (en) * 2000-04-06 2001-10-18 Novartis Ag Derivatives of alpha-mercaptoacetamide
US6777443B2 (en) 2001-05-15 2004-08-17 Novartis Ag Dipeptide derivatives
WO2003027091A1 (en) * 2001-09-21 2003-04-03 Novartis Ag Pyrane derivatives as both ace- and nep- inhibitors
AR038377A1 (es) 2002-02-08 2005-01-12 Merck & Co Inc Derivados de n-bifenil-aminocicloalcancarboxamida (con sustitucion con metilo)
ATE316954T1 (de) 2002-02-08 2006-02-15 Merck & Co Inc N-biphenylmethylaminocycloalkancarboxamid- derivative
DE60336986D1 (de) 2002-03-05 2011-06-16 Sumitomo Chemical Co Verfahren zur herstellung von biarylverbindungen
JP2006511562A (ja) * 2002-12-20 2006-04-06 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系疾患の処置のための置換２，５−ジアミドインドール類の使用
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
CA2551789C (en) * 2004-01-12 2011-05-03 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
AU2007205578B2 (en) * 2006-01-11 2012-06-28 Seikagaku Corporation Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP4047365B2 (ja) 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
JP3975226B2 (ja) 2006-01-11 2007-09-12 生化学工業株式会社 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN104725279B (zh) * 2015-02-12 2018-03-02 威海迪素制药有限公司 一种N‑Boc‑联苯丙氨酸衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504302A (ja) * 1993-11-01 1997-04-28 日本チバガイギー株式会社 エンドセリン・レセプター・アンタゴニスト
EP0655461B1 (en) * 1993-11-16 2000-06-07 Novartis AG Cyclic amino acid derivatives having ACE and NEP inhibiting activity
FR2745571B1 (fr) * 1996-03-04 1998-06-19 Inst Nat Sante Rech Med Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
PL343594A1 (en) 2001-08-27
KR20010034816A (ko) 2001-04-25
ZA200004680B (en) 2001-04-25
IL138246A0 (en) 2001-10-31
CN1297453A (zh) 2001-05-30
EP1073674A1 (en) 2001-02-07
NO20005293D0 (no) 2000-10-20
AU3819999A (en) 1999-11-16
NO20005293L (no) 2000-12-18
RU2000129510A (ru) 2002-11-10
JP4350306B2 (ja) 2009-10-21
SK15812000A3 (sk) 2001-03-12
ID26822A (id) 2001-02-15
CA2323691A1 (en) 1999-11-04
JP2002513032A (ja) 2002-05-08
BR9909805A (pt) 2000-12-26
HUP0101640A2 (hu) 2001-09-28
WO1999055726A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
PL343007A1 (en) Inhibitors of phospholipase enzymes
IL137718A0 (en) Inhibitors of phospholipase enzymes
EP1127054A4 (en) INHIBITORS OF IMPDH ENZYME
IL138387A0 (en) Enzyme inhibitors
AU3665199A (en) Inhibitors of impdh enzyme
AP9700973A0 (en) Inhibitors of IMPDH enzyme
AP9701054A0 (en) Inhibitors of cycteine protease
PL350911A1 (en) Inhibitors of impdh enzyme
PL349192A1 (en) Protease inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
IL133368A0 (en) Urokinase inhibitors
HUP0101640A3 (en) Certain thoil inhibitors of endothelin-converting enzyme
PL328665A1 (en) Inhibitors of serinic protease
PL337725A1 (en) Inhibitors of proteases
EP1093367A4 (en) PROTEASE INHIBITORS
PL334975A1 (en) Application of gasto-intestinal lipase inhibitors
AU9059798A (en) Urokinase inhibitors
EP0994707A4 (en) INHIBITORS OF NAALADASE ENZYMATIC ACTIVITY
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
GB9425701D0 (en) Enzyme inhibitors
EP1067894A4 (en) PROTHEASEINHIBITOREN
ZA983065B (en) Inhibitors of protein farnesyltranferase
EP1079821A4 (en) PROTEASE INHIBITORS
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
GB9924522D0 (en) Enzyme inhibitors